<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01795001</url>
  </required_header>
  <id_info>
    <org_study_id>S55133</org_study_id>
    <nct_id>NCT01795001</nct_id>
  </id_info>
  <brief_title>The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy</brief_title>
  <official_title>The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fund for Scientific Research, Flanders, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Funds for Research in Ophthalmology, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mieke Perdaens fund for Eye Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gain further insights into the molecular pathogenesis of
      Fuchs' endothelial corneal dystrophy (FECD), to identify targets for potential specific drug
      therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">September 13, 2017</completion_date>
  <primary_completion_date type="Actual">September 13, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cytokine levels</measure>
    <time_frame>at time of prelevation (once, no intervention)</time_frame>
    <description>dosage of cytokine levels in aqueous humour (exploratory, non-interventional study)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>gene expression levels</measure>
    <time_frame>at time of prelevation (once, no intervention)</time_frame>
    <description>microarray expression analysis, reverse transcriptase - quantitative polymerase chain reaction (RT-qPCR), RNA-sequencing (exploratory, non-interventional study)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>protein content</measure>
    <time_frame>at time of prelevation (once, no intervention)</time_frame>
    <description>immunohistochemistry and immunofluorescence</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">460</enrollment>
  <condition>Fuchs' Endothelial Dystrophy</condition>
  <arm_group>
    <arm_group_label>late-onset FECD</arm_group_label>
    <description>tissue samples from patients with late-onset Fuchs' endothelial corneal dystrophy (FECD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal control</arm_group_label>
    <description>tissue samples from patients with normal corneas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-FECD edematous control</arm_group_label>
    <description>tissue samples from patients with corneal edema but without FECD</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>late-onset FECD</arm_group_label>
    <arm_group_label>normal control</arm_group_label>
    <arm_group_label>non-FECD edematous control</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Non-interventional study on corneal endothelium, anterior eye chamber fluid and
      paraffin-embedded corneal tissue, using molecular techniques to identify and characterise the
      molecular players involved in the pathogenesis of FECD.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Fuchs' Endothelial Corneal Dystrophy (FECD), normal control patients, and
        patients with non-Fuchs edematous corneas; in university hospital setting.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  FECD

          -  normal corneas (including enucleations for uveal melanoma)

          -  non-FECD oedematous corneas

        Exclusion Criteria:

          -  prior irradiation therapy for uveal melanoma

          -  corneal extension of uveal melanoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joost J van den Oord, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Translational Cell and Tissue Research - campus Sint-Raf - UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2013</study_first_submitted>
  <study_first_submitted_qc>February 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2013</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pathophysiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
    <mesh_term>Iridocorneal Endothelial Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>MEA and RT-qPCR data have been deposited in NCBI's Gene Expression Omnibus and are accessible through the Gene Expression Omnibus Series accession number GSE75676.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

